Ionization states of the catalytic residues in HIV-1 protease

被引:134
作者
Smith, R
Brereton, IM
Chai, RY
Kent, SBH
机构
[1] UNIV QUEENSLAND, CTR MAGNET RESONANCE, BRISBANE, QLD 4072, AUSTRALIA
[2] SCRIPPS RES INST, LA JOLLA, CA 92037 USA
来源
NATURE STRUCTURAL BIOLOGY | 1996年 / 3卷 / 11期
关键词
D O I
10.1038/nsb1196-946
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemical synthesis was used to prepare the HIV-1 protease specifically C-13-labelled in the catalytically essential Asp 25 in each monomer, The NMR chemical shift of the C-13-enriched homodimeric enzyme was measured in the presence of the inhibitor pepstatin, a mimic of the tetrahedral intermediate formed in enzyme catalysis, In this complex, the catalytic carboxyls do not titrate in the pH range where the enzyme is active; throughout the range pH 2,5-6.5, one Asp 25 side chain is protonated and the other deprotonated, By contrast, in the absence of inhibitor the two Asp side chains are chemically equivalent and both deprotonated at pH 6, the optimum for enzymatic activity, These direct observations of the chemical properties of the catalytic apparatus of the enzyme provide concrete information on which to base the design of improved HIV-1 protease inhibitors.
引用
收藏
页码:946 / 950
页数:5
相关论文
共 28 条
[1]   KINETIC-PROPERTIES OF HIV-1 PROTEASE PRODUCED BY TOTAL CHEMICAL SYNTHESIS WITH CYSTEINE RESIDUES REPLACED BY ISOSTERIC L-ALPHA-AMINO-N-BUTYRIC ACID [J].
BERGMAN, DA ;
ALEWOOD, D ;
ALEWOOD, PF ;
ANDREWS, JL ;
BRINKWORTH, RI ;
ENGLEBRETSEN, DR ;
KENT, SBH .
LETTERS IN PEPTIDE SCIENCE, 1995, 2 (02) :99-107
[2]   AIDS research - Results on new AIDS drugs bring cautious optimism [J].
Cohen, J .
SCIENCE, 1996, 271 (5250) :755-756
[3]   IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J].
CONDRA, JH ;
SCHLEIF, WA ;
BLAHY, OM ;
GABRYELSKI, LJ ;
GRAHAM, DJ ;
QUINTERO, JC ;
RHODES, A ;
ROBBINS, HL ;
ROTH, E ;
SHIVAPRAKASH, M ;
TITUS, D ;
YANG, T ;
TEPPLER, H ;
SQUIRES, KE ;
DEUTSCH, PJ ;
EMINI, EA .
NATURE, 1995, 374 (6522) :569-571
[4]  
FITZGERALD PMD, 1990, J BIOL CHEM, V265, P14209
[5]   A LOW-BARRIER HYDROGEN-BOND IN THE CATALYTIC TRIAD OF SERINE PROTEASES [J].
FREY, PA ;
WHITT, SA ;
TOBIN, JB .
SCIENCE, 1994, 264 (5167) :1927-1930
[6]   2-STEP BINDING MECHANISM FOR HIV PROTEASE INHIBITORS [J].
FURFINE, ES ;
DSOUZA, E ;
INGOLD, KJ ;
LEBAN, JJ ;
SPECTOR, T ;
PORTER, DJT .
BIOCHEMISTRY, 1992, 31 (34) :7886-7891
[7]   USE OF PROTEIN UNFOLDING STUDIES TO DETERMINE THE CONFORMATIONAL AND DIMERIC STABILITIES OF HIV-1 AND SIV PROTEASES [J].
GRANT, SK ;
DECKMAN, IC ;
CULP, JS ;
MINNICH, MD ;
BROOKS, IS ;
HENSLEY, P ;
DEBOUCK, C ;
MEEK, TD .
BIOCHEMISTRY, 1992, 31 (39) :9491-9501
[8]  
HARTSUCK JA, 1972, J BIOL CHEM, V247, P2575
[9]   SYNTHETIC AND ENZYME-INHIBITION STUDIES OF PEPSTATIN ANALOGS CONTAINING HYDROXYETHYLENE AND KETOMETHYLENE DIPEPTIDE ISOSTERES [J].
HOLLADAY, MW ;
SALITURO, FG ;
RICH, DH .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (02) :374-383
[10]   HIV PROTEASE - A NOVEL CHEMOTHERAPEUTIC TARGET FOR AIDS [J].
HUFF, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) :2305-2314